Yong Rao

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Yong Rao, Zhiqi Kuang, Chan Li et al. · Gut Microbes · 2021 · 340 citations · Full text

Life Sciences, Biology, Microbiology +15

Analogues of xanthones——Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates

Chao‐Yun Cai, Li Rao, Yong Rao et al. · European Journal of Medicinal Chemistry · 2017 · 99 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Natural alkaloid bouchardatine ameliorates metabolic disorders in high‐fat diet‐fed mice by stimulating the sirtuin 1/liver kinase B‐1/AMPK axis

Yong Rao, Hong Yu, Lin Gao et al. · British Journal of Pharmacology · 2017 · 49 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors

Chenxi Wang, Zi-Lin Zhang, Qikun Yin et al. · Journal of Medicinal Chemistry · 2020 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis/lipogenesis in 3T3-L1 adipocytes

Yong Rao, Hong Liu, Lin Gao et al. · Bioorganic & Medicinal Chemistry · 2015 · 47 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14